Definitive Contract 75F40122C00135
Award Date
9/1/22
Potential Completion Date
3/29/28
Potential Value
$1.3M
Federal Agency
Food and Drug Administration
Awardee
VA State Board Of Health
Ultimate Awardee
Not listed
NAICS Category
923120 - Administration of Public Health Programs
PSC Category
H199 - Quality Control- Miscellaneous
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Richmond, VA 23219, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract awarded by the Food and Drug Administration (FDA) to the Commonwealth of Virginia State Board of Health Office of Epidemiology Division, doing business as Office of Epidemiology-Central Office. The contract has a ceiling value of $371,732.40 and is a definitive, firm fixed-price contract. The contract period of performance is from September 30, 2015 to September 29, 2016, with one option period. The contract is not set aside. The contract provides for services...
This is a definitive contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to the Commonwealth of Virginia State Board of Health, Office of Epidemiology, for mammography inspection services. The contract has a potential value of $1,889,156.14 and was awarded on September 18, 2017, with a completion date of September 29, 2022. The contract is a firm fixed-price contract, and there is no set-aside designation mentioned. In addition to...
This $1,177,784.02 firm fixed-price federal contract was awarded by the Food and Drug Administration (FDA) to the Washington State Department of Health to conduct inspections of certified non-federal mammography facilities and ensure compliance with quality standards under the Mammography Quality Standards Act (MQSA). The contract has an ultimate completion date of July 21, 2027. This sole source contract was awarded without a set-aside. The Washington State Department of Health, as a state...
This is a $456,571.04 firm-fixed-price federal contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services. The contract was awarded to the Virginia State Board of Health's Office of Emergency Preparedness, doing business as the Emergency Preparedness & Response Programs. This is a fee-for-service contract with a final completion date of September 29, 2022. It does not have a set-aside designation. The available...
The U.S. Food and Drug Administration (FDA) awarded a $2,482,950.23 Firm Fixed Price contract to the Michigan Department of Labor and Economic Opportunity (MDLEO), doing business as the Talent Investment Agency, to implement the Mammography Quality Standards Act (MQSA). The contract, awarded without any set-aside designation, runs through March 2022 and requires MDLEO to provide specialized regulatory oversight and services to ensure the quality and safety of mammography facilities. As a state...
This is a definitive, firm fixed-price contract awarded by the Food and Drug Administration (FDA) to the West Virginia Department of Health and Human Resources (WVDHHR) Bureau for Public Health. The contract, valued at $849,833.11, is for the performance of Mammography Quality Standards Act (MQSA) inspections in Charleston, West Virginia. The contract does not have a set-aside designation. The WVDHHR Bureau for Public Health is the prime contractor and is a state government entity. This contract...
This is a $2,685,565.01 firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to the Massachusetts Department of Public Health (MDPH) for Massachusetts MQSA (Mammography Quality Standards Act) new contract services. The contract has no set-aside designation and an ultimate completion date of January 21, 2028. MDPH, a U.S. state government agency, is the prime contractor and will provide specialized public health services to the FDA, including food and tobacco...
This is a $501,949.66 firm fixed price contract awarded by the Food and Drug Administration (FDA) to the Rhode Island Department of Health to conduct inspections of mammography facilities in Rhode Island under the Mammography Quality Standards Act (MQSA). The contract has an ultimate completion date of January 14, 2028. The Rhode Island Department of Health, a U.S. state government entity, will be the prime contractor delivering these inspection services. This contract award is not associated...
This is a definitive contract awarded by the Department of Health and Human Services Food and Drug Administration to the Massachusetts Department of Public Health, a U.S. state government entity, for Mass MQSA (Mammography Quality Standards Act) inspections. The contract has a firm fixed price pricing type and a potential value of $1,711,136.29. It was awarded on June 1, 2017 with a completion date of June 30, 2022. This contract is not associated with a larger vehicle and does not have a...
This is a firm-fixed price contract awarded by the Food and Drug Administration (FDA) to the Ohio Department of Health (ODH) to conduct Mammography Quality Standards Act (MQSA) inspections of certified non-federal mammography facilities in Ohio. The contract has a base year award value of $370,904.16 and a ceiling value of $1,928,987.04 over the 5-year period of performance through July 2027. The contract was awarded sole-source to ODH, as a state government organization with the legal authority...